Drug: G-CSF (Dong-A pharmaceutical, Seoul, Korea)

TERMINATED · PHASE2 · Myocardial Infarction

Unknown stopping reason

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.